Netflix CEO Ted Sarandos tries to solve his movie problem

Netflix, which announced a proposed acquisition of Warner Bros. Discovery on December 5, is attempting to reassure Hollywood it will preserve theatrical distribution, with co-CEO Ted Sarandos committing to a minimum 45-day exclusive theatrical window for future Warner Bros. releases and pledging to operate WBD's theatrical distribution largely as-is. The pledge follows years of Netflix favoring streaming-first releases and comes amid skepticism from industry stakeholders and competitive positioning by Paramount — which is also courting WBD and publicly promises to honor traditional theatrical windows — creating lingering uncertainty about how a combined streaming/theatrical strategy would affect box-office revenue and talent relations.

Analysis

Market structure: A Netflix acquisition of WBD re-centers bargaining power toward studios that control theatrical catalogs; immediate winners are theatrical exhibitors and premium-format vendors (IMAX) who get firmer windows, while pure-streaming peers face pricing pressure and NFLX equity dilution risk. Expect box-office revenue concentration in tentpole releases (top 10% of titles generate >50% of revenue), which raises volatility in studio free cash flow and increases value of theatrical distribution assets.

Risk assessment: Key tail risks are a DOJ/FTC antitrust challenge or financing/board defeat that could collapse a deal — probability material within 3–9 months and binary for stocks involved. Short-term (days–weeks) volatility will spike on filings and shareholder votes; medium (3–12 months) integration and talent-contract frictions will determine realized synergies; long-term (12–36 months) outcome depends on Netflix’s willingness to sustain a 45-day floor vs. moving to shorter windows internationally.

Trade implications: Event-driven equity and options trades favor being long WBD and IMAX and structurally short or hedged vs. NFLX: capture takeover spread, theatrical-premium re-rating, and dilution risk respectively. Use options to define risk — e.g., buy 6–9 month NFLX put spreads (10/20% OTM) as cheap insurance while owning WBD stock or calls; rotate 10–25% of streaming growth allocation into experiential/media names across the next 2–6 weeks.

Contrarian angles: Consensus assumes Netflix will aggressively shorten windows post-close; that underestimates brand/talent and exhibitor leverage — a 45-day floor could persist and re-rate theatrical-related equities higher by 10–30% if enforced. Conversely, if regulators block the deal, WBD could gap down while NFLX recovers — asymmetric outcomes justify asymmetric sizing and option-defined exposure.

Key Decisions for Investors

• Establish a 3–4% long position in WBD (equity) as an event-driven play; hedge with 6–9 month WBD calls if premium exceeds 6% of position cost; target exit on deal close or a 20–30% realized gain, cutoff at 25% loss.
• Initiate a 1.5–2% short or hedge against NFLX (equity) exposure via buying 6-month put spreads (buy 10% OTM, sell 20% OTM) sized to cost ~0.3–0.6% of portfolio — protects vs. dilution/regulatory downside; unwind on clear regulatory approval or within 9 months.
• Add a 1–2% long position in IMAX to capture firmer theatrical windows and premium-format demand; hold 6–18 months and trim if IMAX trades up >30% or if studios signal return to streaming-first releases.
• Reduce pure streaming growth exposure by 15–25% over the next 2–6 weeks; reallocate proceeds into diversified media/exhibition names (WBD, IMAX) and buy option-defined protection for remaining streaming positions against regulatory or integration shocks.
• Set specific catalysts to act: monitor DOJ/FTC filing and WBD shareholder meeting dates (expect material moves within next 90–180 days), and treat a court/agency action or formal financing announcement as a trigger to reweight positions by 50%.